Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China; Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
J Biotechnol. 2024 Nov 20;395:71-79. doi: 10.1016/j.jbiotec.2024.09.008. Epub 2024 Sep 17.
Macrolactins have attracted considerable attention due to their value and application in medicine and agriculture. However, poor yields severely hinder their broader application in these fields. This study aimed to improve macrolactins production in Bacillus siamensis using a combined atmospheric and room-temperature plasma mutagenesis and a microbial microdroplet culture system. After 25 days of treatment, a desirable strain with macrolactins production 3.0-fold higher than that of the parental strain was successfully selected. The addition of 30 mg/L ZnSO further increased macrolactins production to 503 ± 37.6 μg/mL, representing a 30.9 % improvement in production compared to controls. Based on transcriptome analysis, the synthesis pathways of amino acids, fengycin, and surfactin were found to be downregulated in IMD4036. Further fermentation experiments confirmed that inhibition of the comparative fengycin synthesis pathway was potentially driving the increased production of macrolactins. The strategies and possible mechanisms detailed in this study can provide insight into enhancing the production of other secondary metabolites toxic to the producer strains.
大环内酯类化合物因其在医学和农业领域的价值和应用而受到广泛关注。然而,产量低严重限制了它们在这些领域的更广泛应用。本研究旨在使用大气压和室温等离子体诱变和微生物微滴培养系统来提高解淀粉芽孢杆菌中大环内酯类化合物的产量。经过 25 天的处理,成功筛选到一株比亲本菌株产量高 3 倍的理想菌株。添加 30mg/L 的 ZnSO4 进一步将大环内酯类化合物的产量提高到 503±37.6μg/mL,与对照相比,产量提高了 30.9%。基于转录组分析,发现 IMD4036 中氨基酸、丰原素和表面活性剂的合成途径下调。进一步的发酵实验证实,比较丰原素合成途径的抑制可能是导致大环内酯类化合物产量增加的原因。本研究中详细介绍的策略和可能的机制可为提高其他对产生菌有毒的次生代谢产物的产量提供思路。